OPTFSNA
ELOX

Old Point Trust & Financial Services N A’s Eloxx Pharmaceuticals ELOX Stock Holding History

Old Point Trust & Financial Services N A’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69 Buy
+5
New +$64 ﹤0.01% 321

Other funds holding ELOX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PFO
Pioneer Family Office North Miami Beach, Florida $194M AUM
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Old Point Trust & Financial Services N A's ELOX Position: Q2 2026 in Review

Old Point Trust & Financial Services N A opened a new position in Eloxx Pharmaceuticals (ELOX) in Q2 2026: 5 shares worth $69. The stake represents ﹤0.01% of the portfolio and ranks #321 among its holdings.

14 funds tracked by Wall St. Rank hold ELOX as of Q2 2026.

  • Old Point Trust & Financial Services N A held 5 shares of Eloxx Pharmaceuticals worth $69 as of Q2 2026.
  • Eloxx Pharmaceuticals was a new Old Point Trust & Financial Services N A position in Q2 2026.
  • Eloxx Pharmaceuticals made up ﹤0.01% of Old Point Trust & Financial Services N A's portfolio in Q2 2026, its #321 holding.
  • 14 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q2 2026.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2026, filed 30 Jul 2026.